| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MDIA3
|
17.28 | 5.8B | 8.32 | 0.69 | 3.64 | 8.1% | 16.8% | 80 | 49 | 33.47 | +70.2% | 91 | 0.21 |
|
LREN3
|
10.90 | 10.5B | 6.47 | 1.01 | 3.56 | 25.5% | 15.6% | 78 | 67 | 22.43 | +79.3% | 76 | 0.32 |
|
AZZA3
|
14.86 | 3.0B | 3.61 | 0.38 | 4.24 | 5.3% | 11.5% | 74 | 60 | 33.44 | +93.7% | 58 | 0.49 |
|
JBSS3
|
13.80 | 14.7B | 1.65 | 0.35 | 3.56 | 11.8% | 6.6% | 70 | 72 | 35.94 | +110.7% | 52 | 2.81 |
|
SMTO3
|
19.75 | 6.4B | 7.62 | 0.87 | 6.69 | 6.4% | 11.1% | 68 | 41 | 31.26 | +39.0% | 57 | 1.35 |
|
ABEV3
|
15.03 | 228.1B | 14.04 | 2.58 | 7.22 | 25.0% | 17.9% | 61 | 47 | 13.24 | -8.9% | 89 | 0.03 |
|
AMER3
|
5.10 | 1.0B | — | 0.23 | 3.21 | 0.5% | 7.4% | 53 | 35 | 9.70 | +53.1% | 39 | 1.26 |
|
MGLU3
|
4.81 | 3.7B | 27.28 | 0.33 | 5.31 | 4.9% | 11.3% | 51 | 56 | 8.77 | +59.2% | 44 | 0.76 |
|
ASAI3
|
9.15 | 12.3B | 17.51 | 2.08 | 5.75 | 10.6% | 11.8% | 48 | 43 | 8.24 | -6.7% | 38 | 4.60 |
|
SLCE3
|
16.07 | 8.0B | 24.62 | 1.50 | 6.81 | 7.5% | 11.8% | 46 | 31 | 12.45 | -15.1% | 44 | 2.05 |
|
WEGE3
|
50.15 | 210.4B | 34.28 | 11.16 | 20.29 | 37.7% | 17.4% | 43 | 35 | 15.42 | -51.9% | 95 | 0.31 |
|
PCAR3
|
2.73 | 1.3B | — | 2.03 | 23.01 | -0.7% | 7.8% | 13 | 27 | 0.73 | -31.5% | 13 | 12.64 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.